Bispecific antibodies are artificial proteins that can bind to two different antigens at the same time.
Bispecific antibodies are an exciting and novel way to treat some blood cancers.
Bispecific antibodies used in the treatment of B-cell lymphoma include: Glofitamab, Epcortimab, Mosunetutzumab and Odronextamab.
Bispecific antibodies used in the treatment of myeloma include Teclistamab and Talquetamab.